Jiufei Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiufei Fang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Zhishun Liu
Department of Acupuncture and Moxibustion, Guang'anmen Hospital, China Academy of Chinese Medical Sciences
7 shared publications - He Chen
Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China
5 shared publications - Xinyu Shen
Graduate College, Beijing University of Chinese Medicine, Beijing, People’s Republic of China
4 shared publications - Shuai Gao
Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
3 shared publications - Hao Yao
Department of Acupuncture, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China
2 shared publications - Lili Zhu
Department of Acupuncture, Shanghai Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in Integrative Medicine Research
Acupuncture for low back pain in older adults with degenerative lumbar spinal stenosis: a secondary analysis of a randomized clinical trial
- 21 October 2026
- Published by Elsevier in Integrative Medicine Research
Open AccessAcupuncture for low back pain in older adults with degenerative lumbar spinal stenosis: a secondary analysis of a randomized clinical trial
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-10
Prognostic Factors and Treatment Effect Modifiers for Acupuncture Response in Patients with Neurogenic Claudication of Degenerative Lumbar Spinal Stenosis: Secondary Analysis of a Randomized Controlled Trial
Purpose: Acupuncture has shown its efficacy in improving pain-specific disability among patients with degenerative lumbar spinal stenosis (DLSS) who predominantly present with neurogenic claudication pain symptoms. It is still unclear which group of the patients have better response to acupuncture. This secondary analysis of a randomized controlled trial aimed to identify potential prognostic factors and treatment effect modifiers of response to acupuncture in DLSS patients with neurogenic claudication. Patients and Methods: A secondary analysis was conducted based on a multi-center randomized controlled trial, where 196 DLSS patients were randomized to acupuncture or sham acupuncture and 178 completed the 6-week intervention. Responders were defined by a 2-point reduction in the modified Roland-Morris Disability Questionnaire (RMDQ) score from baseline to week 6. Baseline characteristics were summarized using descriptive statistics. Seventeen baseline characteristics were considered as potential prognostic factors of response and subjected to logistic regression analysis. Results: Among the 178 patients included in this secondary analysis, 119 were defined as responders. Treatment assignment (OR 2.0977; 95% CI 1.0300 to 4.2721; p = 0.0412), age (OR 1.0684, 95% CI 1.0176 to 1.1217; p = 0.0078), and Swiss Spinal Stenosis Questionnaire (SSSQ) symptom severity score (OR 1.1270; 95% CI 1.0077 to 1.2606; p = 0.0363) were positively associated with patient response. Patients with a shorter duration of the current episode (OR 0.9384; 95% CI 0.9020 to 0.9764; p = 0.0017) might specifically benefit more from acupuncture. Conclusion: DLSS patients with receiving acupuncture, older age, higher SSSQ symptom severity score, and shorter duration of current episode may be more likely to be responder. Duration of current episode modifies the response of acupuncture. These findings provide preliminary evidence to inform patient selection and warrant validation in future studies.
- 1 August 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-10
Open AccessPrognostic Factors and Treatment Effect Modifiers for Acupuncture Response in Patients with Neurogenic Claudication of Degenerative Lumbar Spinal Stenosis: Secondary Analysis of a Randomized Controlled Trial
Purpose: Acupuncture has shown its efficacy in improving pain-specific disability among patients with degenerative lumbar spinal stenosis (DLSS) who predominantly present with neurogenic claudication pain symptoms. It is still unclear which group of the patients have better response to acupuncture. This secondary analysis of a randomized controlled trial aimed to identify potential prognostic factors and treatment effect modifiers of response to acupuncture in DLSS patients with neurogenic claudication. Patients and Methods: A secondary analysis was conducted based on a multi-center randomized controlled trial, where 196 DLSS patients were randomized to acupuncture or sham acupuncture and 178 completed the 6-week intervention. Responders were defined by a 2-point reduction in the modified Roland-Morris Disability Questionnaire (RMDQ) score from baseline to week 6. Baseline characteristics were summarized using descriptive statistics. Seventeen baseline characteristics were considered as potential prognostic factors of response and subjected to logistic regression analysis. Results: Among the 178 patients included in this secondary analysis, 119 were defined as responders. Treatment assignment (OR 2.0977; 95% CI 1.0300 to 4.2721; p = 0.0412), age (OR 1.0684, 95% CI 1.0176 to 1.1217; p = 0.0078), and Swiss Spinal Stenosis Questionnaire (SSSQ) symptom severity score (OR 1.1270; 95% CI 1.0077 to 1.2606; p = 0.0363) were positively associated with patient response. Patients with a shorter duration of the current episode (OR 0.9384; 95% CI 0.9020 to 0.9764; p = 0.0017) might specifically benefit more from acupuncture. Conclusion: DLSS patients with receiving acupuncture, older age, higher SSSQ symptom severity score, and shorter duration of current episode may be more likely to be responder. Duration of current episode modifies the response of acupuncture. These findings provide preliminary evidence to inform patient selection and warrant validation in future studies.
- Open Access
- 20 March 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3)
Nonsurgical interventions for lumbar spinal stenosis with neurogenic claudication: A systematic review and network meta-analysis
- 20 March 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3)
Open AccessNonsurgical interventions for lumbar spinal stenosis with neurogenic claudication: A systematic review and network meta-analysis
- Open Access
- 1 October 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 5359-5376
Long Term Effects of Acupuncture for Primary Dysmenorrhea: A Systematic Review and Meta-Analysis
Objective: Primary dysmenorrhea (PD) is a recurrent disease. The current treatments for PD often fail to provide long-lasting effects, underscoring the necessity for new treatment options that can offer durable benefits. Previous studies have indicated that the durable effect of acupuncture for PD remains uncertain. In this review, we aimed to evaluate the durable effect after completion of treatment. Methods: Both English and Chinese literature were comprehensively retrieved from eight databases up to January 24, 2025. Two independent reviewers conducted screening and data extraction. The risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Meta-analysis was conducted where applicable. Pooled continuous data were expressed as mean differences (MD) and the safety outcomes were expressed through odds ratio (OR). Results: Fourteen randomized controlled trials enrolled 970 patients met the inclusion and exclusion criteria. Acupuncture outperformed no intervention in reducing pain intensity measured by visual analogue scale (VAS) (MD − 47.80; 95% CI − 48.63 to − 46.97; p < 0.0001) and Short-Form McGill Pain Questionnaire (MD − 8.55; 95% CI − 11.46 to − 5.64; p < 0.0001), Cox Menstrual Symptom Scale (CMSS) duration score (MD − 18.24; 95% CI − 22.39 to − 14.09; p < 0.0001) and severity score (MD − 12.96; 95% CI − 16.41 to − 9.51; p < 0.0001) at 3 menstrual cycles post-treatment. Compared to non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture showed superior pain relief measured by VAS (MD − 29.89; 95% CI − 37.63 to − 22.15; p < 0.0001), and symptom amelioration measured by CMSS (MD − 3.00; 95% CI − 5.92 to − 0.08; p = 0.0043) at 3 cycles post-treatment. Acupuncture also enhanced NSAIDs’ analgesic effect measured by VAS (MD − 19.95; 95% CI − 24.23 to − 15.66; p < 0.0001). However, acupuncture presented no superiority over sham acupuncture at 3 menstrual cycles post-treatment. Conclusion: Acupuncture might provide durable post-treatment effects to primary dysmenorrhea patients up to three menstrual cycles, which was limited by high risk of bias and low certainty evidence.
- 1 October 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 5359-5376
Open AccessLong Term Effects of Acupuncture for Primary Dysmenorrhea: A Systematic Review and Meta-Analysis
Objective: Primary dysmenorrhea (PD) is a recurrent disease. The current treatments for PD often fail to provide long-lasting effects, underscoring the necessity for new treatment options that can offer durable benefits. Previous studies have indicated that the durable effect of acupuncture for PD remains uncertain. In this review, we aimed to evaluate the durable effect after completion of treatment. Methods: Both English and Chinese literature were comprehensively retrieved from eight databases up to January 24, 2025. Two independent reviewers conducted screening and data extraction. The risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool. Meta-analysis was conducted where applicable. Pooled continuous data were expressed as mean differences (MD) and the safety outcomes were expressed through odds ratio (OR). Results: Fourteen randomized controlled trials enrolled 970 patients met the inclusion and exclusion criteria. Acupuncture outperformed no intervention in reducing pain intensity measured by visual analogue scale (VAS) (MD − 47.80; 95% CI − 48.63 to − 46.97; p < 0.0001) and Short-Form McGill Pain Questionnaire (MD − 8.55; 95% CI − 11.46 to − 5.64; p < 0.0001), Cox Menstrual Symptom Scale (CMSS) duration score (MD − 18.24; 95% CI − 22.39 to − 14.09; p < 0.0001) and severity score (MD − 12.96; 95% CI − 16.41 to − 9.51; p < 0.0001) at 3 menstrual cycles post-treatment. Compared to non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture showed superior pain relief measured by VAS (MD − 29.89; 95% CI − 37.63 to − 22.15; p < 0.0001), and symptom amelioration measured by CMSS (MD − 3.00; 95% CI − 5.92 to − 0.08; p = 0.0043) at 3 cycles post-treatment. Acupuncture also enhanced NSAIDs’ analgesic effect measured by VAS (MD − 19.95; 95% CI − 24.23 to − 15.66; p < 0.0001). However, acupuncture presented no superiority over sham acupuncture at 3 menstrual cycles post-treatment. Conclusion: Acupuncture might provide durable post-treatment effects to primary dysmenorrhea patients up to three menstrual cycles, which was limited by high risk of bias and low certainty evidence.
- Open Access
- 13 September 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (1) , 101253
Effect of electroacupuncture versus prucalopride for ultra-severe chronic constipation: Secondary analysis of a randomized controlled trial
- 13 September 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (1) , 101253
Open AccessEffect of electroacupuncture versus prucalopride for ultra-severe chronic constipation: Secondary analysis of a randomized controlled trial
- Open Access
Efficacy and safety of two-step acupuncture therapy for symptom relief in adults with mild to moderate ulcerative colitis: rationale and design of the TSA-UC randomised controlled trial
Introduction Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) characterised by episodes of symptoms including rectal bleeding, increased stool frequency and abdominal pain, impacting quality of life significantly. Conventional treatments often come with potential side effects and may not be sufficient. Acupuncture is increasingly recognised for its potential benefits in UC. This study aims to assess the efficacy and safety of acupuncture for symptom relief in mild to moderate UC. Methods and analysis This single-centre, parallel-arm, randomised, sham-controlled, the two-step acupuncture (TSA)-UC trial, will involve 64 adults with mild to moderate UC, randomly assigned in a 1:1 ratio to either the acupuncture or sham acupuncture group. Participants will receive 20 sessions of two-step acupuncture or sham acupuncture therapy over 8 weeks. Blinding will be applied to participants, outcome assessors and statisticians. The primary outcome measure is the change in Patient-Reported Outcome 2 (PRO2) from baseline at week 8. Secondary outcomes include changes from baseline in the following scales: PRO2 at other time points, weekly average Numeric Rating Scale (NRS) for bowel urgency, weekly average NRS for abdominal pain (both associated and not associated with bowel movement), the 32-item Inflammatory Bowel Disease Questionnaire, Work Productivity and Activity Impairment Questionnaire-IBD, Pittsburgh Sleep Quality Index and Hospital Anxiety and Depression Scale. The Patient Global Impression of Change will also be assessed. Long-term effects of acupuncture will be explored. Adverse events and additional treatments will be monitored throughout the study. The modified intention-to-treat population including participants who complete baseline assessments and receive at least one treatment session will be analysed. Ethics and dissemination The study has received ethical approval from the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences (2024-190-KY). The results will be published in a peer-reviewed medical journal. Trial registration number NCT06615765.
Open AccessEfficacy and safety of two-step acupuncture therapy for symptom relief in adults with mild to moderate ulcerative colitis: rationale and design of the TSA-UC randomised controlled trial
Introduction Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) characterised by episodes of symptoms including rectal bleeding, increased stool frequency and abdominal pain, impacting quality of life significantly. Conventional treatments often come with potential side effects and may not be sufficient. Acupuncture is increasingly recognised for its potential benefits in UC. This study aims to assess the efficacy and safety of acupuncture for symptom relief in mild to moderate UC. Methods and analysis This single-centre, parallel-arm, randomised, sham-controlled, the two-step acupuncture (TSA)-UC trial, will involve 64 adults with mild to moderate UC, randomly assigned in a 1:1 ratio to either the acupuncture or sham acupuncture group. Participants will receive 20 sessions of two-step acupuncture or sham acupuncture therapy over 8 weeks. Blinding will be applied to participants, outcome assessors and statisticians. The primary outcome measure is the change in Patient-Reported Outcome 2 (PRO2) from baseline at week 8. Secondary outcomes include changes from baseline in the following scales: PRO2 at other time points, weekly average Numeric Rating Scale (NRS) for bowel urgency, weekly average NRS for abdominal pain (both associated and not associated with bowel movement), the 32-item Inflammatory Bowel Disease Questionnaire, Work Productivity and Activity Impairment Questionnaire-IBD, Pittsburgh Sleep Quality Index and Hospital Anxiety and Depression Scale. The Patient Global Impression of Change will also be assessed. Long-term effects of acupuncture will be explored. Adverse events and additional treatments will be monitored throughout the study. The modified intention-to-treat population including participants who complete baseline assessments and receive at least one treatment session will be analysed. Ethics and dissemination The study has received ethical approval from the Ethics Committee of Guang’anmen Hospital, China Academy of Chinese Medical Sciences (2024-190-KY). The results will be published in a peer-reviewed medical journal. Trial registration number NCT06615765.
- Open Access
- 3 April 2023
- Published by Elsevier in Integrative Medicine Research
- Vol. 12 (2) , 100943
Impact of ejaculation upon effect of acupuncture on chronic prostatitis/chronic pelvic pain syndrome: Secondary analysis of a randomized controlled trial
- 3 April 2023
- Published by Elsevier in Integrative Medicine Research
- Vol. 12 (2) , 100943
Open AccessImpact of ejaculation upon effect of acupuncture on chronic prostatitis/chronic pelvic pain syndrome: Secondary analysis of a randomized controlled trial